Dr. Amanda Guth is an assistant professor in the Department of Clinical Sciences at Colorado State University. After earning her DVM from Colorado State University, she started a post-doc position studying tumor immunology that led to her present day interest in understanding the immune response to tumors.

Dr. Guth’s current interests lie in combining novel ways to block immune-inhibitory cells to enhance the effects of tumor vaccines and other immunotherapies. She has recently been focusing on developing vaccines targeting cancer stem cells and studying a novel method for generating whole cell, autologous tumor vaccines, both in mouse models and in client-owned dogs.